Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-13 4:28 pm Purchase |
2022-01-03 | 13G | Edgewise Therapeutics, Inc. EWTX |
Citadel Advisors LLC | 2,489,284 5.000% |
30,761 (+1.25%) |
Filing History |
| 2022-01-13 4:27 pm Purchase |
2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Citadel Advisors LLC | 2,458,523 5.000% |
3,199 (+0.13%) |
Filing History |
| 2021-07-12 4:07 pm Purchase |
2021-07-01 | 13G | Edgewise Therapeutics, Inc. EWTX |
Citadel Advisors LLC | 2,455,324 5.000% |
2,455,324 (New Position) |
Filing History |
| 2021-05-18 4:08 pm Purchase |
2021-05-13 | 13G | Edgewise Therapeutics, Inc. EWTX |
Cormorant Global Healthcare Master Fund LP | 2,590,914 5.260% |
2,590,914 (New Position) |
Filing History |
| 2021-04-30 6:44 pm Purchase |
2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX |
U.S. Venture Partners XI L.P. | 3,489,168 7.100% |
3,489,168 (New Position) |
Filing History |
| 2021-04-07 6:00 pm Purchase |
2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX |
ORBIMED ADVISORS LLC | 13,679,055 27.800% |
13,679,055 (New Position) |
Filing History |
| 2021-04-05 3:20 pm Purchase |
2021-03-26 | 13G | Edgewise Therapeutics, Inc. EWTX |
VIKING GLOBAL INVESTORS LP | 3,352,281 7.000% |
3,352,281 (New Position) |
Filing History |
| 2021-03-31 4:31 pm Purchase |
2020-03-25 | 13D | Edgewise Therapeutics, Inc. EWTX |
Novo Holdings A/S | 5,587,207 11.400% |
5,587,207 (New Position) |
Filing History |
| 2021-03-30 3:40 pm Purchase |
2021-03-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 3,933,137 8.270% |
3,933,137 (New Position) |
Filing History |